Literature DB >> 26070161

Application of quantitative NMR for purity determination of standard ACE inhibitors.

Shi Shen1, Xing Yang2, Yaqin Shi3.   

Abstract

This study investigated the accuracy of the quantitative NMR method for purity determination of ACE inhibitors reference standards and the discovery of two pairs of new diastereoisomers. Six types of ACE inhibitors, imidapril hydrochloride, benazepril hydrochloride, lisinopril, enalapril maleate, quinapril hydrochloride, and captopril were quantificated and validated for the qNMR method by discussing factors that affect parameters of the qNMR experiment, internal standards, integration, pH-effect, and uncertainty. The results were compared with data obtained by the mass balance method. The study found that maleic acid influenced the quantification of captopril in deuteroxide because of a chemical reaction. The mixtures of the reaction products were isolated by HPLC and structurally elucidated by NMR as two pairs of new diastereoisomers, 1-[(2S,4R)-thio-2-methylpropionyl-5-d-ethanedicarboxylicacid]-L-proline and 1-[(2S,4S)-thio-2-methylpropionyl-5-d-ethanedicarboxylicacid]-L-proline. The results showed that the accuracy and precision of quantitative (1)H NMR spectroscopy satisfied the requirements for quantitative analysis of chemical reference standards and provided a simple, rapid, and reliable method for purity determination of ACE inhibitors systematically.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ACE inhibitors; Captopril; Diastereoisomers; Thiol-ene click reaction; qNMR

Mesh:

Substances:

Year:  2015        PMID: 26070161     DOI: 10.1016/j.jpba.2015.05.021

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  1 in total

1.  Direct Comparison of (19)F qNMR and (1)H qNMR by Characterizing Atorvastatin Calcium Content.

Authors:  Yang Liu; Zhaoxia Liu; Huaxin Yang; Lan He
Journal:  J Anal Methods Chem       Date:  2016-09-01       Impact factor: 2.193

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.